NCT07150793

A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan

Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan - A Retrospective Claims Database Analysis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 754 (actual)
• Sponsor: Novartis Pharmaceuticals · Industry
• Sex: All
• Age: 15 Years
• Healthy volunteers: Not accepted

Summary

The main goal of this study was to describe treatment patterns of patients with chronic myeloid leukemia (CML) who were treated with tyrosine kinase inhibitors (TKIs) in Japan. This was a retrospective observational study with secondary use of data from the Medical Data Vision (MDV) hospital-based database. The index date was the date of the first prescription of any TKI of interest registered within the selection period (01 January 2011 to 31 December 2019). The follow-up period was from the index date until the end of the study period, end of continuous follow-up in the MDV database, or death, whichever came first.

Conditions

• Myeloid Leukemia, Chronic

Timeline

• Start date: 2022-07-05
• Primary completion: 2023-02-08
• Completion: 2023-02-08
• First posted: 2025-09-02
• Last updated: 2025-09-02

Locations

1 site across 1 country: United States